Tony Castro

Experience

• 

  Enterprise - Fleet Management Sales Division

  Oct 1999 - Jan 2003

  Account Executive

  B2B outsides sales position selling fleet management programs to medium to large businesses operating a fleet of vehicles for their business purposes.Cold call high ranking executives (CEO/CFO) to try to sell them on fleet programs whose goal was to lower operating costs and increase efficiencies in the management of their fleet through the Enterprise vehicle lease program and ancillary products and services.

• 

  Renaissance Fine Marble

  Jan 2000 - Dec 2014

  Vice President

  Responsible for in the hiring of sales staff, the implementation of a goal-based quota/compensation system for the sales staff, accounting, marketing, P&L, and operational decisions with a significant financial impact on the business. Stone fabrication and installation business for high-end residential and commercial businesses.• Successfully coached sales staff and negotiated over $32.8 million dollars of sales from 2000 to 2014.• Developed a complete and full understanding of how to run a successful business from the ground up (hiring, marketing, payroll, general liability, workers compensation, accounting, IRS audit, etc.) • Implemented a new corporate marketing and promotion strategy that included a new corporate logo, brochures, an online web presence, a direct to consumer marketing strategy, and a B2B marketing strategy.• Restructured the business focus of the company after the “ 2006 Real Estate bubble” and successfully navigated the company to higher profit margins and larger contracts despite a palpable contraction in the Southern California building market place. Show less

• 

  Eli Lilly and Company

  Feb 2003 - Dec 2009

  Senior Sales Representative

  Successfully managed territories in multiple sections of the city and to multiple medical specialties.Neuroscience Hospital, Neuroscience Primary Care, Long Term Care, Women's Health, Men's Health, and Cardiovascular. 4 consecutive years of Top 10% performance or better (national ranking).• 2009 ranked in the Top 1% Nationally for overall Sales portfolio (7 out of 468).• 2009 ranked #1 sales representative in the entire West Area.• 2008 Ranked in the Top 8% in the Nation (15 out of 180) for overall sales portfolio • 2007 Ranked in the Top 10% in the nation (19 out of 184) for overall Sales Portfolio • 2006 Ranked in the Top 3% in the nation (17 out of 513) for overall Sales Portfolio • Awarded the “Turn Around Award for 2006.” Was transferred to the territory ranked #497 out of 513 (88% to quota). At the end of the year had moved up 480 spots in the ranking to finish the year ranked #17. • 2004 Ranked in the top 24% in the nation for overall Sales Portfolio (108 out of 450). Show less

• 

  Auxilium Biopharmaceuticals

  Jan 2010 - Jul 2014

  Biotech Specialty Account Manager / Reimbursement

  Orthopedic Sales Account Manager – Los Angeles, Las Vegas, HawaiiSuccessfully launched Xiaflex, an expensive “orphan drug” injectable biologic, for Dupuytren’s Contracture of the hand. Positioned Xiaflex as a first line therapy to Orthopedic Surgeons, Plastic Surgeons, Rheumatologists, and Hand Surgeons across three states. Responsible for the continued growth of Xiaflex, protecting and cultivating the base business, and ensuring the integration of Xiaflex onto hospital and institution formulary. Required to have expertise with CPT codes, J-Codes, and ICD-9 codes in order to ensure approval of Xiaflex followed by the proper reimbursement of the medication and procedure codes.• Fiscal Year 2012 Presidents Club Award Winner. Ranked #6 out of 62• Fiscal Year 2011 Grew the business by 100% year over year. • Fiscal Year 2011 Successfully executed a business plan that included the acceptance of Xiaflex onto the UCLA, Cedars Sinai, Las Vegas VA, and the Tripler Army Hospital/VA formulary grids.• Fiscal Year 2010 Presidents Club Award Winner. Ranked #9 out of 72• Complete knowledge of the “Buy & Bill” and “Specialty Pharmacy” model of acquiring high priced biologics• Proven ability to provide coding and reimbursement coaching to clients in order to ensure proper reimbursement of Xiaflex across multiple payers (Medicare, private insurance, HMOs, & IPAs). ICD-9 codes, Procedure codes CPT, and J-codes. Show less

• 

  Questcor / Mallinckrodt

  Jul 2014 - Jan 2015

  Autoimmune & Rare Disease Specialist: Acthar

  Autoimmune and Rare Diseases Neurology SpecialistPromote H.P. Acthar Gel, a high priced injection for the treatment of acute exacerbations in Multiple Sclerosis, in the treatment of Infantile Spasms, Dermatomyositis and Polymyositis. Responsibilities also include product pull through in an orphan disease reimbursement model.• In the first two months in the field added 28 new Neurology physicians to an outdated call database.• Extended the territory boundaries into Bakersfield, a geography that had previously been neglected• Successfully coordinated and launched the 2014 Bakersfield MS Society Walk• Partnered with the Neuroscience Foundation to participate in a patient educational forum and exhibit to further advance patient education and advocacy • Identified the Neuroscience Center of Ventura as a potential MS treatment center. Partnered and established an Acthar protocol for relapse readiness. Show less

• 

  Horizon/Amgen

  Jan 2015 - now

  Clinical Science Associate for the West Coast

  10 year average National Sales Ranking of #2 in the NationInterim National Sales Director 2023o Leading strategic planning for brand, National Sales Meeting, Conferences, and cross functional collaborationo Helped to develop and implemented new Active Ship Patient tracking tool for the nationo Most new shipments since Q2 2021o Exceeded historical Q1 average by 2.6%o Exceeded on-label demand for the first time since Q2 2022Responsible for the re-launch of Actimmune (interferon gamma-1b) in the West Coast for Chronic Granulomatous Disease, and Severe, Malignant, Osteopetrosis, two ultra rare orphan drug disease states. Responsible for identifying treating providers, building clinical support, and increasing overall awareness of the product and disease states to facilitate new patient starts and drive referrals into patient services HUB. Business development is focused around Pediatric and Adult Hematology, Oncology, Infectious Diseases, Pulmonology, Allergy, and Immunology physicians and treatment centers.Promoted Ravicti for Urea Cycle Disorder. Responsible for building relationships with Metabolic geneticists, general geneticists, genetic counselors, and dietitians. • Fiscal Year 2024 Ranked #2 in the Nation. • Fiscal Year 2023 Ranked #5 in the Nation. • Fiscal Year 2022 Ranked #2 in the Nation. • Fiscal Year 2022 National Rare Disease Business Unit Excellence in Collaboration Award Winner • Fiscal Year 2021 Ranked #1 in the Nation. Presidents Club • Fiscal Year 2020 Ranked #2 in the Nation. • Fiscal Year 2019 Ranked #1 in the Nation. Presidents Club• Fiscal Year 2018 Ranked #2 in the Nation• Fiscal Year 2017 Ranked #4 in the Nation• Fiscal Year 2016 Chairman’s Award • Fiscal Year 2016 Ranked #1 in the Nation. Presidents Club • Fiscal Year 2015 Ranked #3 in the Nation• Responsible for the management, protection, expansion, and growth of a book of business worth over 33 million dollars per year. Show less

• 

  Horizon

  Jan 2023 - Sept 2023

  National Sales Director